GlaxoSmithkline Pharmaceuticals Limited inobhadhara rini?GlaxoSmithkline Pharmaceuticals Limited inobhadhara chikamu kune gore negore, kubhadhara kwekupedzisira kwezvikamu paGLAXO.BO zvigaro kwaiva 19/07/2021. Shanduro ipi iyo GlaxoSmithkline Pharmaceuticals Limited inobhadhara?Iyo kambani GlaxoSmithkline Pharmaceuticals Limited yakabhadhara 30 Rs chikamu chimwe nechimwe nguva yekupedzisira uye mugove wekugoverwa kwegore negore waiva 1.87 %. Ndeipi chikamu chinotevera chekubhadhara zuva GlaxoSmithkline Pharmaceuticals Limited?Chikamu chinotevera chekugoverwa kwezvikamu zveGlaxoSmithkline Pharmaceuticals Limited inotarisirwa musi Chikunguru 2024. Inopatsanurwa pane zvikamu zve GlaxoSmithkline Pharmaceuticals Limited - iyo mari yakawandisa, inoratidza kushanda zvakanaka kwekudyara mari muzvikamu zvekambani ino. Misi uye huwandu hwemakero ekugovera hunotarwa nekambani. Iyo yekugovera yekubhadhara mhedzisiro ndiyo yehukuru maitiro ekuchinja mukukosha kwemasheya. Sevhisi yedu inoratidza nhoroondo yemari yekugovera kubhadhara GlaxoSmithkline Pharmaceuticals Limited uye kufanotaura kwekubhadhara kwemigove. Nhoroondo yekugovera ye GlaxoSmithkline Pharmaceuticals Limited inowanikwa kwenguva pfupi iri muchimiro chechita uye kwenguva yakareba iri muchimiro chetafura. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Zvigadziriswa GlaxoSmithkline Pharmaceuticals Limited mushure mekubhadharaKwemazuva akasiyana ekubhadhara, chati yekugovera ye GlaxoSmithkline Pharmaceuticals Limited inodhonza iyo ikholamu yayo. Zviri nyore zvakakwana kuti utarise masimba ehuwandu hwemigove yakagashirwa, uchiongorora kukwirira kwemakoramu echati. GlaxoSmithkline Pharmaceuticals Limited gadziriso yezvikamu inowanikwa munguva chaiyo. Chirongwa chekugovera che GlaxoSmithkline Pharmaceuticals Limited gore rapfuura chinonyanya kuoneka. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Chikamu chekubhadhara chikamu GlaxoSmithkline Pharmaceuticals LimitedMazuva ekubhadharwa kwemigove pa GLAXO.BO migove inoratidzwa patafura yebasa yepamhepo. Mutsetse mumwe wetafura une zuva rekubhadhara. Nehuwandu hwemitsara iri patafura yegore, unogona kunzwisisa kuti kangani migove yakabhadharwa kune GlaxoSmithkline Pharmaceuticals Limited yegore. Zuva razvino rekubhadhara zuva rekubhadhara GlaxoSmithkline Pharmaceuticals Limited iri pamzere wekutanga petafura. Iwe unogona kuona saizi yemigove ye GlaxoSmithkline Pharmaceuticals Limited yezuva rinodikanwa mukoramu yechipiri yetafura yekudyidzana. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Kuwanda kwemabhadharo ekugovera kune GlaxoSmithkline Pharmaceuticals Limited patafura inoratidzwa chikamu chimwe nechimwe. Iko mari yekuratidza iyo yekugovera chikamu chekubhadhara iri GlaxoSmithkline Pharmaceuticals Limited - dhora. Dhaivha goho GlaxoSmithkline Pharmaceuticals Limited - chiyero chakayerwa chakaenzana nehuremu hwehuwandu hwemari inopihwa gore rimwe chete kune kukosha kwechikamu chimwe che GlaxoSmithkline Pharmaceuticals Limited yeiyo nguva yekugadzirisa. Iyo yekugovera goho ye GlaxoSmithkline Pharmaceuticals Limited shares ikozvino iri pabasa redu repamhepo - 1.87 %. Kugovera goho GlaxoSmithkline Pharmaceuticals Limited ndiyo yekutanga chiratidzo kune uyo anodyara, masimba emutengo wemasheya ndiwo wechipiri. Tevera ese metric mumasevhisi edu epamhepo. Nhoroondo ye GlaxoSmithkline Pharmaceuticals Limited goho rekugovera chiratidzo chikuru chebudiriro yekambani pane imwe nguva yakareba. Nhoroondo yekugovera zvibereko mune yedu GlaxoSmithkline Pharmaceuticals Limited tafura yezvigadziriso tafura inowanikwa kune yekupedzisira makumi maviri emitero. Iwe uchawana ichangoburwa GlaxoSmithkline Pharmaceuticals Limited goho remidhiya mumutsara wekutanga wefurafura. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Mari yezvikamu GlaxoSmithkline Pharmaceuticals Limited |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Mari GlaxoSmithkline Pharmaceuticals Limited |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
|